Peak Pharmaceuticals (OTCMKTS:PKPH) Shares Down 4.9%

Peak Pharmaceuticals, Inc. (OTCMKTS:PKPHGet Rating)’s share price dropped 4.9% on Tuesday . The stock traded as low as $0.14 and last traded at $0.14. Approximately 107,627 shares traded hands during trading, a decline of 39% from the average daily volume of 176,048 shares. The stock had previously closed at $0.15.

Peak Pharmaceuticals Stock Performance

The company’s 50 day simple moving average is $0.09 and its two-hundred day simple moving average is $0.07.

About Peak Pharmaceuticals

(Get Rating)

Peak Pharmaceuticals, Inc does not have significant operations. Previously, it was operated as a bio­pharmaceutical and nutraceutical company, as well as focuses to develop, manufacture, market, and sell medicinal products based on extracts from hemp. The company was formerly known as Cannabis Therapy Corporation and changed its name to Peak Pharmaceuticals, Inc in December 2014.

Featured Stories

Receive News & Ratings for Peak Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Peak Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.